Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides
Open Access
- 2 May 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 94 (11), 1697-1702
- https://doi.org/10.1038/sj.bjc.6603147
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Annals of Oncology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node‐negative breast cancerInternational Journal of Cancer, 2003
- Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinomaCancer, 2003
- Expression of cyclins E, A, and B, and prognosis in lymph node‐negative breast cancerThe Journal of Pathology, 2003
- Over-expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomasInternational Journal of Cancer, 2001
- The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapySeminars in Cancer Biology, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990